Voltadvance 25 mg powder for oral solution

Voltadvance is an over-the-counter anti-inflammatory and analgesic medication specifically used for the treatment of various types of pain, such as joint or muscle pain and headaches. The brand 'Voltaren' (from which Voltadvance is derived) was originally developed by Ciba-Geigy in Switzerland.

Following a series of corporate mergers and demergers involving Novartis and GSK, the consumer healthcare division was spun off into a new independent entity called Haleon in 2022. Today, Haleon owns the brand globally. Production for the Italian market, as indicated by the Haleon Italy S.r.l. label, often takes place at specialized pharmaceutical sites within Italy or central Europe to serve the local healthcare infrastructure.